Corrigendum: Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma

Detalles Bibliográficos
Autores principales: Lu, Hanwen, Zhou, Liwei, Zhang, Bingchang, Xie, Yuanyuan, Yang, Huiyin, Wang, Zhanxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364843/
https://www.ncbi.nlm.nih.gov/pubmed/37492249
http://dx.doi.org/10.3389/fmed.2023.1244638
_version_ 1785076927782977536
author Lu, Hanwen
Zhou, Liwei
Zhang, Bingchang
Xie, Yuanyuan
Yang, Huiyin
Wang, Zhanxiang
author_facet Lu, Hanwen
Zhou, Liwei
Zhang, Bingchang
Xie, Yuanyuan
Yang, Huiyin
Wang, Zhanxiang
author_sort Lu, Hanwen
collection PubMed
description
format Online
Article
Text
id pubmed-10364843
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-103648432023-07-25 Corrigendum: Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma Lu, Hanwen Zhou, Liwei Zhang, Bingchang Xie, Yuanyuan Yang, Huiyin Wang, Zhanxiang Front Med (Lausanne) Medicine Frontiers Media S.A. 2023-07-10 /pmc/articles/PMC10364843/ /pubmed/37492249 http://dx.doi.org/10.3389/fmed.2023.1244638 Text en Copyright © 2023 Lu, Zhou, Zhang, Xie, Yang and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Lu, Hanwen
Zhou, Liwei
Zhang, Bingchang
Xie, Yuanyuan
Yang, Huiyin
Wang, Zhanxiang
Corrigendum: Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma
title Corrigendum: Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma
title_full Corrigendum: Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma
title_fullStr Corrigendum: Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma
title_full_unstemmed Corrigendum: Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma
title_short Corrigendum: Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma
title_sort corrigendum: cuproptosis key gene fdx1 is a prognostic biomarker and associated with immune infiltration in glioma
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364843/
https://www.ncbi.nlm.nih.gov/pubmed/37492249
http://dx.doi.org/10.3389/fmed.2023.1244638
work_keys_str_mv AT luhanwen corrigendumcuproptosiskeygenefdx1isaprognosticbiomarkerandassociatedwithimmuneinfiltrationinglioma
AT zhouliwei corrigendumcuproptosiskeygenefdx1isaprognosticbiomarkerandassociatedwithimmuneinfiltrationinglioma
AT zhangbingchang corrigendumcuproptosiskeygenefdx1isaprognosticbiomarkerandassociatedwithimmuneinfiltrationinglioma
AT xieyuanyuan corrigendumcuproptosiskeygenefdx1isaprognosticbiomarkerandassociatedwithimmuneinfiltrationinglioma
AT yanghuiyin corrigendumcuproptosiskeygenefdx1isaprognosticbiomarkerandassociatedwithimmuneinfiltrationinglioma
AT wangzhanxiang corrigendumcuproptosiskeygenefdx1isaprognosticbiomarkerandassociatedwithimmuneinfiltrationinglioma

Ejemplares similares